Charles Schultz Email & Phone Number

San Diego, California, United States

The Woodlands, Tx

Corporate Communication, Patient Advocacy, Rare Disease, Type 1 Diabetes, Multimillion-dollar P&L, Program Development, Leadership➥MY ROLE: Promoted to Senior Director and then again to Executive Director, I report directly to the CFO and hold P&L accountability for all corporate communications and patient advocacy departments and oversee all community and patient interactions, internal motivation, and communications. As Executive Director, I oversee and drive internal development and motivation across the company as well as internal events and corporate outreach. I am also a key team member for the approval and launch of our first rare disease product and a potential new treatment for type 1 diabetes.➥MY IMPACT:✓ Led the development of the first corporate patient advocacy group from the ground up by establishing relationships and trust throughout the orphan NET patient community to best navigate an entrenched competitive landscape.✓Led the corporate transition from R&D to commercial sales with the launch of first drug; launched “Defy Possible” movement as flagship platform to drive sales and inspire internal culture; became centerpiece for national sales meeting and cover for annual report. Produced several inspirational videos around “Defy Possible.”✓Presented at 2018 Supporting the Patient Experience Conference with 60 attendees: “Know Your Audience – Strategies for Successfully Connecting to Targeted Patient Populations”✓Lead presenter for first full day of 2019 CBI Nurse Educator Programs Conference with 150 attendees: “Elevate Meaningful Patient Engagement Programs to Advance Education and Outcomes”✓Led 15 additional public speaking engagements including radio to promote and connect Lexicon to local community.

The Woodlands, Tx

➥MY ROLE: In this role, I manage community, local, regional, and national events, corporate marketing, and engagement. I also serve as corporate spokesperson to build and maintain our corporate reputation and trust with the neuroendocrine tumor (NETs) and type one diabetes (T1D) communities. ➥MY IMPACT:✓Helped to revitalize Xermelo sales growth by creating an innovative and humorous patient marketing program “CS Happens”; fast-tracked commercial video production, gained FDA marketing approval, and launched programs in six cities across the U.S.; won Tapestry Award for raising awareness and connection in the NETs community. ✓Created and led a corporate connection initiative to connect the employees with the local JDRF T1D community; converted 15,000 sq ft of vivarium space into a “Haunted Hallway” where children and parents living with T1D could experience a spooky fun filled evening with Lexicon employees; over 50% employee participation; $10,000+ raised for JDRF; spotlighted at the national JDRF annual Industry Advisory Panel; now an annual event.

The Woodlands, Tx

Investor Relations, Annual Reporting, Financial Modeling, Budgeting, Financial Forecasting➥MY ROLE: As Senior Director, I served as a direct report to the CFO and as Head of the Investor Relations department, overseeing all investor interactions including investor calls, presentations, investor conferences and meetings, roadshows, investor days, annual report development. ➥MY IMPACT:✓Built and presented to the board of directors extensive “what-if” corporate financial modeling, analysis and recommendations for corporate cost-cutting restructuring scenarios.✓Maintained financial budgeting and forecasting systems for all corporate operations .✓Sole financial modeling and valuation leader in all drug program valuations; conducted extensive modeling including DCF and Monte Carlo valuations.✓Raised $1.0B in corporate, debt, and equity transactions as key team member of development and offering teams.

The Woodlands, Tx

Investor Relations, Financial Analysis, Drug Discovery/Research, Startup, Financial Modeling, Rare Disease ➥MY ROLE: Recruited to oversee investor relations and financial analysis, I built a cross-functional investor relations team from the ground-up shortly after going public in April 2000. As head of the investor relations department, I oversaw all investor interactions including investor calls, presentations, investor conferences and meetings, roadshows, investor days, and annual report development.➥MY IMPACT:✓Provided high-level of operational freedom and reported directly to CFO.✓Built and maintained financial budgeting and forecasting systems from the ground-up for all corporate operations including 40 cost centers and 100 drug discovery programs.✓Sole financial modeling and valuation leader in all transaction and drug program valuations; conducted extensive modeling including DCF and Monte Carlo valuations that resulted in substantial deal economics gains.✓Delivered insights, suggestions and valuations on business deal terms to guide and benefit Lexicon deal negotiations. ✓Played lead role in capital planning, presenting operational options to the board of directors. ✓Led investor team on 10 different financing transactions, raising over $850M in equity and corporate transactions. ✓Served as investment banker on the team and completed $220M IPO for Lexicon, largest biotechnology IPO to-date.

The Woodlands, Tx

➥MY ROLE: I conducted intense financial modeling for the overall company and specific programs, including DCF and Monte Carlo valuations of all company drug programs.

Greater New York City Area

➥MY ROLE: I oversaw work on private placements, IPOs, follow-on offerings, M&A transactions, and company valuations.➥MY IMPACT:✓Served as lead deal member for $800M in biotechnology company transactions.

Greater New York City Area

➥MY ROLE: I was a key member of the team during $1.4B in biotechnology, oil & gas, retail, and technology transactions.

Bachelor Of Science (B.S.), Accounting And Finance

Graduated Magna Cum Laude Dean's List 1994 & 1995

High School Diploma - International Baccalaureate Diploma, International Baccalaureate Degree